Atectura Breezhaler 150 mcg (Indacaterol (Indacaterol Acetate) CAPSULE) 150 MCG

ATECTURA BREEZHALER 150 MCG is a medication containing indacaterol acetate, used for managing respiratory conditions. This inhalation capsule is designed for easy administration via the BREEZHALER device, offering a convenient treatment option for those requiring long-term respiratory support.

Strength

150 MCG

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ATECTURA BREEZHALER 150 MCG is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Indacaterol, the active ingredient, helps to relax the muscles in the airways, making it easier to breathe. This medication is often prescribed for individuals who require long-term management of their respiratory symptoms.

Side Effects

Common effects of ATECTURA BREEZHALER 150 MCG may include headache, dizziness, and throat irritation. Some users might experience coughing or a dry mouth. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

ATECTURA BREEZHALER 150 MCG should be used with caution in individuals with certain medical conditions, such as heart disease or high blood pressure. It is important to follow the prescribed dosage and administration instructions carefully. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

ATECTURA BREEZHALER 150 MCG may interact with other medications, including beta-blockers and certain antidepressants. It is also advisable to avoid alcohol while using this medication, as it can exacerbate some side effects. Always consult a healthcare provider before starting any new medication.

Frequently Asked Questions

ATECTURA BREEZHALER 150 MCG is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).

ATECTURA BREEZHALER 150 MCG is administered via inhalation using the BREEZHALER device. Follow the instructions provided by your healthcare provider.

Common side effects may include headache, dizziness, throat irritation, coughing, and dry mouth.

ATECTURA BREEZHALER 150 MCG may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

ATECTURA BREEZHALER 150 MCG is designed for long-term use in managing COPD. However, regular follow-ups with a healthcare provider are recommended.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.